Breathing is one of the few bodily functions we can consciously control. Dr. Konstantin Buteyko, a Soviet‐era physician, built a structured training program around this fact. He argued that chronic overbreathing (hyperventilation) depletes the body’s natural stores of carbon‑dioxide, causes constriction of blood vessels and bronchi, and aggravates a wide range of disorders.
His method trains people to breathe slowly, through the nose, and to pause gently after exhalation – a practice he believed restores carbon‑dioxide balance and calms the nervous system. Although the claim that hyperventilation causes “150 diseases” is controversial, modern practitioners and researchers are revisiting his technique with an open mind.
From Theory to Practice
The Buteyko breathing technique (BBT) combines education and structured exercises. Participants learn to become aware of their breathing patterns, keep their mouths closed, breathe quietly through the nose and perform deliberate pauses called the control pause (CP). Exercises often include gentle breath reduction (reduced breathing) and periods of breath holding, with a focus on relaxing the diaphragm and minimising the use of accessory muscles. This retraining is usually delivered in group sessions followed by home practice, and many instructors encourage lifestyle changes such as stress management and nasal breathing at night.
Evidence from Clinical Studies
Several recent trials have explored the physiological and psychological effects of Buteyko breathing. While most studies are small and many lack blinding, the results hint at meaningful benefits when the technique is used alongside conventional therapy.
Asthma in adults
A 2024 randomized controlled trial involving adults with asthma compared usual medical care with usual care plus BBT. After three months, the Buteyko group had improved symptom scores on the Asthma Control Questionnaire (ACQ) and the Nijmegen Questionnaire, and a small increase in bronchial volume, despite significantly reducing their respiratory medication. The researchers noted that participants accepted the self‑controlled therapy and suggested that BBT could serve as a supportive tool in asthma management.
Asthma in children
An Egyptian study of school‑age children with bronchial asthma found that four weeks of Buteyko training produced clinically significant improvements in asthma control (p = 0.0001), increased peak expiratory flow and longer control pauses, and a decrease in heart rate. The authors concluded that the technique promoted better respiratory outcomes and should be considered as part of childhood asthma care.
Hypertension and functional capacity
Investigators in India randomly assigned 66 adults with primary hypertension to either standard care or standard care plus BBT for four weeks. The experimental group experienced a mean reduction in systolic blood pressure of 8.6 ± 6.31 mmHg and diastolic blood pressure of 4.606 ± 4.34 mmHg, alongside reductions in resting heart rate and improvements in the control pause and six‑minute walk distance. The authors concluded that Buteyko breathing had a positive effect on haemodynamic parameters and functional capacity in essential hypertension.
Psychological rehabilitation after heart surgery
A 2023 randomised clinical trial assessed the impact of adding Buteyko breathing to phase‑1 cardiac rehabilitation in patients recovering from coronary artery bypass graft (CABG) surgery. Both the control and experimental groups received conventional rehabilitation, but the experimental group practised BBT for two weeks. On follow‑up, the Buteyko group showed greater reductions in anxiety and depression scores, higher self‑efficacy, longer breath‑holding times and lower perceived exertion than the control group. The study concluded that incorporating BBT into early cardiac rehabilitation yielded favourable psychological outcomes.
Other reported benefits
Literature summaries cited by Mehta et al. note that small studies in hypertensive patients and university athletes found decreases in systolic and diastolic blood pressure, reductions in resting heart rate and improvements in control pause, VO₂ max and other cardiorespiratory parameters following Buteyko training. These reports, while preliminary, suggest that breath retraining may influence circulatory and performance metrics.
Beyond Asthma: Conditions Linked to Overbreathing
Buteyko and his followers attributed numerous disorders to chronic overbreathing. English‑language lists compiled by advocates at the Breathing Center and The Breathing Man reproduce his catalogue of ailments. These sources enumerate around 80 categories that expand to about 107 distinct conditions when their sub‑conditions are counted. Buteyko argued that low carbon‑dioxide levels provoke spasms, tissue hypoxia and metabolic disturbances that aggravate these problems. The table below presents the most complete list available in the public domain. Inclusion in this table reflects historical assertions rather than confirmed causal relationships.
| No. | Condition or disease linked to overbreathing |
|---|---|
| 1 | Allergic respiratory disease |
| 2 | Polyvalent allergy (pollen disease) |
| 3 | Laryngospasm (voice loss) |
| 4 | Allergic conjunctivitis |
| 5 | Food allergies |
| 6 | Drug allergies |
| 7 | Pseudocroup (false spasmodic croup) |
| 8 | Pharyngitis |
| 9 | Laryngitis |
| 10 | Tracheitis |
| 11 | Asthmatic bronchitis |
| 12 | Bronchial asthma |
| 13 | Chronic bronchitis |
| 14 | Chronic pneumonia |
| 15 | Bronchiectasis |
| 16 | Pneumosclerosis |
| 17 | Emphysema |
| 18 | Silicosis |
| 19 | Anthracosis |
| 20 | Chronic cold (chronic rhinitis) |
| 21 | Vasomotor rhinitis |
| 22 | Frontal sinusitis |
| 23 | Maxillary sinusitis |
| 24 | Sinusitis |
| 25 | Adenoids and polyps |
| 26 | Chronic rhinosinusitis |
| 27 | Pollinoses (hay fever) |
| 28 | Quincke’s oedema (angioedema) |
| 29 | Hives (urticaria) |
| 30 | Neurodermatitis |
| 31 | Psoriasis |
| 32 | Diathesis |
| 33 | Vitiligo |
| 34 | Ichthyosis |
| 35 | Acne |
| 36 | Raynaud’s disease (vascular spasms of the extremities) |
| 37 | Obliterating endarteritis |
| 38 | Varicose veins |
| 39 | Thrombophlebitis |
| 40 | Haemorrhoids |
| 41 | Hypotension |
| 42 | Hypertension |
| 43 | Autonomic neuropathy (vegetative‑vascular dystonia) |
| 44 | Congenital heart disease |
| 45 | Rheumatism of the joints |
| 46 | Rheumatic heart disease |
| 47 | Diencephalic syndrome |
| 48 | Ischemic heart disease (IHD) |
| 49 | Angina pectoris (rest and exertional) |
| 50 | Postinfarction cardiosclerosis |
| 51 | Tachycardia |
| 52 | Extrasystole |
| 53 | Paroxysmal tachycardia (PSVT) |
| 54 | Atrial fibrillation |
| 55 | Generalised atherosclerosis |
| 56 | Arachnoiditis |
| 57 | Paralysis (post‑stroke) |
| 58 | Paresis (partial paralysis) |
| 59 | Parkinson’s disease (initial stage) |
| 60 | Hypothyroidism |
| 61 | Hyperthyroidism |
| 62 | Graves’ disease |
| 63 | Diabetes mellitus |
| 64 | Irregular menstruation |
| 65 | Toxaemia of pregnancy (morning sickness / pre‑eclampsia) |
| 66 | Menopausal problems |
| 67 | Cervical erosion |
| 68 | Fibromyoma (uterine fibroids) |
| 69 | Fibrocystic breast changes (mastopathy) |
| 70 | Infertility |
| 71 | Impotence |
| 72 | Threatened miscarriage |
| 73 | Radiculitis (nerve‑root syndrome) |
| 74 | Osteochondrosis |
| 75 | Metabolic polyarthropathy |
| 76 | Rheumatoid polyarthropathy |
| 77 | Dupuytren’s contracture |
| 78 | Gout |
| 79 | Pyelonephritis |
| 80 | Glomerulonephritis |
| 81 | Nocturia (need to urinate at night) |
| 82 | Cystitis |
| 83 | Kidney stone disease (urolithiasis) |
| 84 | Obesity |
| 85 | Lipomatosis |
| 86 | Chronic gastritis |
| 87 | Chronic cholecystitis |
| 88 | Biliary dyskinesia |
| 89 | Chronic pancreatitis |
| 90 | Gallstone disease |
| 91 | Duodenal ulcer |
| 92 | Irritable bowel syndrome |
| 93 | Peptic ulcers (peptic ulcer disease) |
| 94 | Multiple sclerosis |
| 95 | Epileptic syndrome (epilepsy) |
| 96 | Schizophrenia (initial stage) |
| 97 | Scleroderma |
| 98 | Systemic lupus erythematosus |
| 99 | Dermatomyositis |
| 100 | Glaucoma |
| 101 | Cataracts |
| 102 | Temporary squinting (strabismus) |
| 103 | Long‑sightedness (hypermetropia) |
| 104 | Radiation sickness |
| 105 | Acute and chronic hepatitis |
| 106 | Cirrhosis of the liver |
| 107 | HIV/AIDS |
The breadth of this list underscores the ambition of Buteyko’s hypothesis. Modern science does not currently support a direct causal link between hyperventilation and conditions like autoimmune disease, liver cirrhosis or HIV/AIDS, yet the fact that breathing patterns can influence physiology warrants further study. Practitioners often report anecdotal improvements in seemingly unrelated symptoms when clients adopt gentle nasal breathing and breath control. These experiences may reflect broader effects of stress reduction, improved oxygen delivery and enhanced autonomic balance rather than the specific mechanisms proposed by Buteyko.
A Holistic Perspective
What should we make of the Buteyko method today? The evidence above suggests that breath retraining can improve subjective asthma control, reduce reliance on bronchodilators, lower blood pressure and heart rate, and support psychological recovery after surgery. These benefits align with a broader understanding that slow nasal breathing activates the parasympathetic nervous system, improves heart‑rate variability and enhances diaphragmatic function. As with other complementary therapies, the best results arise when BBT is integrated with, rather than substituted for, mainstream medical care.
From a practitioner’s standpoint, the appeal of Buteyko lies in its simplicity and empowerment. It encourages people to cultivate awareness of their breath, maintain nasal breathing during activity and sleep, and apply gentle breath holds to calm the mind. Clients often report feeling more centred, sleeping better and experiencing fewer anxious spikes. While it is unlikely that breathing alone can treat the full catalogue of conditions listed above, regular practice may provide meaningful support for respiratory health, cardiovascular regulation and mental well‑being. Continued research with larger sample sizes and longer follow‑up will clarify the scope of its benefits.
Resources
The following sources informed this article and provide entry points for further exploration:
-
Vagedes K et al. (2024) – Randomised controlled trial of BBT plus usual care versus usual care in adults with asthma; found improved symptom scores despite reduced medication use – pmc.ncbi.nlm.nih.gov.
-
Mohammed Hassan E et al. (2022) – Study of BBT in school‑age children with asthma; reported improved asthma control, increased peak expiratory flow and reduced heart rate – pmc.ncbi.nlm.nih.gov.
-
Arora R et al. (2022) – Trial on primary hypertension; BBT produced significant reductions in systolic and diastolic blood pressure and resting heart rate, and improved functional capacity – medicopublication.com.
-
Jain M et al. (2023) – Randomised clinical trial in CABG patients; adding BBT to cardiac rehabilitation reduced anxiety and depression and improved self‑efficacy compared with rehabilitation alone – jcdr.net.
-
Mehta D et al. (2024) – Research protocol reviewing BBT and breath stacking techniques; summarises previous studies reporting reductions in blood pressure and heart rate and improvements in control pause and VO₂ max – jcdr.net.
-
Breathing Center and The Breathing Man – Advocacy sites that reproduce Buteyko’s list of conditions linked to hyperventilation – breathingcenter.comthebreathingman.com.
-
Egypt J Bronchol introduction to Buteyko theory – Describes Buteyko’s rationale that low carbon‑dioxide levels and hidden hyperventilation underlie numerous disorders – pmc.ncbi.nlm.nih.gov.
These resources include open‑access clinical papers, educational material from Buteyko practitioners and summaries of his theoretical framework. Together, they offer a balanced view of a breathing method that continues to inspire interest and debate among healthcare providers and breathwork enthusiasts.